Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress

Nat Rev Drug Discov. 2012 Feb 1;11(2):96. doi: 10.1038/nrd3655.
No abstract available

Publication types

  • News

MeSH terms

  • Antioxidants / therapeutic use*
  • Drug Industry*
  • Humans
  • Inflammation / drug therapy*
  • NF-E2-Related Factor 2 / agonists*
  • Oleanolic Acid / analogs & derivatives
  • Oleanolic Acid / therapeutic use
  • Oxidative Stress / drug effects*

Substances

  • Antioxidants
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Oleanolic Acid
  • methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate